{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    9,
    20,
    21,
    22
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 2.2, 8.5.4 - Secondary Objectives/Analysis",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Modification of the specific KCCQ scoring metric used for secondary endpoints."
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 1.4, 2.4, 4, 5.8 - Study Design and Objectives",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of a new Echocardiographic Sub-study including objectives and procedures."
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 2.3, 6.3.1, 6.3.2.6 - Safety Objectives",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Expansion of Adverse Events of Interest to include preceding events for amputations."
      },
      {
        "id": "impact_4",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 3.2 - Exclusion Criteria",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Clarification of exclusion criteria and extension of contraceptive requirements."
      },
      {
        "id": "impact_5",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 5.1.1, 5.1.4 - Endpoint Reporting",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Removal of adjudication requirements for specific renal endpoints."
      },
      {
        "id": "impact_6",
        "amendmentId": "amend_v2",
        "affectedSection": "Section 6.4.1 - Reporting of SAEs",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Simplification of SAE reporting by limiting event types withheld from health authorities."
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_v2",
        "reasonText": "Discussion with regulatory authorities regarding amputation risks.",
        "category": "Regulatory",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_v2",
        "reasonText": "Feedback from regulatory authorities and harmonization with the Informed Consent Form (ICF).",
        "category": "Regulatory",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_v2",
        "reasonText": "Endpoint criteria did not justify the adjudication of eGFR decline events.",
        "category": "Scientific",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_4",
        "amendmentId": "amend_v2",
        "reasonText": "Protocol mandated laboratory values are systematically analyzed, making separate AE recording redundant unless meeting SAE/DAE criteria.",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_5",
        "amendmentId": "amend_v2",
        "reasonText": "Minimize risk for withholding renal AEs of interest which could be confused for endpoints.",
        "category": "Safety",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_v2",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "2.2",
        "beforeText": "Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical/overall symptom score",
        "afterText": "Kansas City Cardiomyopathy Questionnaire (KCCQ) total symptom score",
        "summary": "Changed the specific KCCQ score used for secondary variable analysis."
      },
      {
        "id": "change_2",
        "amendmentId": "amend_v2",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "6.3.2.6",
        "beforeText": "AEs leading to amputation",
        "afterText": "AEs leading to amputation and AEs leading to a risk for lower limb amputations (“preceding events”)",
        "summary": "Expanded amputation AE category to include risk-preceding events."
      },
      {
        "id": "change_3",
        "amendmentId": "amend_v2",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "3.2",
        "beforeText": "Exclusion criteria 16",
        "afterText": "Extended requirement for contraceptives (exclusion criteria 16)",
        "summary": "Updated contraceptive requirements based on regulatory feedback."
      },
      {
        "id": "change_4",
        "amendmentId": "amend_v2",
        "changeType": "Deletion",
        "instanceType": "StudyChange",
        "sectionNumber": "5.1.4",
        "beforeText": "Requirement of adjudicating potential endpoints related to eGFR decline",
        "afterText": "null",
        "summary": "Removed adjudication requirement for eGFR decline endpoints."
      },
      {
        "id": "change_5",
        "amendmentId": "amend_v2",
        "changeType": "Clarification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2.7",
        "beforeText": "null",
        "afterText": "Clarification regarding investigator responsibility for standard of care treatment after IP discontinuation",
        "summary": "Added guidelines for post-IP treatment responsibilities."
      }
    ],
    "summary": {
      "impactCount": 6,
      "reasonCount": 5,
      "changeCount": 5
    }
  }
}